Nebius Stock Surges 110% in 6 Months: Time to Buy, Hold or Sell?

Nebius reported Q2 revenue of $582 million, up 454% year over year, with its AI business contributing $575 million, or 98% of the total; adjusted EBITDA rose to $236 million from a $21 million loss a year earlier. It raised its year-end contracted-power target to 5 gigawatts and signed four major contracts averaging more than $1 billion each, but expects $20 billion-$25 billion in 2026 capex and faces elevated-valuation and deployment-timing risks. Shares gained 109.5% over six months; the article advises existing investors to hold while new investors wait for a better entry point, noting a Zacks Rank of Hold.

Analysis

The key underwriting question is not whether AI compute demand exists, but whether Nebius can convert contracted power into revenue and cash returns before financing needs dilute the equity economics. Customer prepayments reduce near-term funding pressure, but they are not free capital: they shift delivery obligations forward and make commissioning delays or customer concentration more consequential. Verify contract duration, counterparty credit, cancellation terms, and whether reported capex is cash paid or committed before extrapolating the spend rate.

Near term, the rally leaves NBIS vulnerable to any financing, schedule, or utilization disappointment. Over the next 1–3 months, watch cash conversion, incremental capacity coming online, and funding mix—not adjusted EBITDA alone. Over 6–18 months, grid connections, construction, GPU availability, and customer onboarding determine whether the power pipeline earns an attractive return; a large contracted-power target is not yet productive capacity.

Competitive spillovers cut both ways. NVIDIA benefits from infrastructure buildout, but as providers scale and customers seek alternatives, GPU supply allocation and pricing power could become less favorable. Microsoft and other hyperscalers can constrain third-party pricing by expanding their own capacity or shifting workloads. CoreWeave offers a useful sector read-through, but not a clean hedge: customer mix, financing, and deployment execution differ. Contrarian point: sold-out capacity can signal scarcity, but it can also conceal rationing and does not establish durable pricing or returns on capital. The bullish case is falsified by repeated commissioning delays, weakening prepayments/utilization, capex funded increasingly by equity or corporate debt, or margin improvement failing to convert into cash.

Key Decisions for Investors

• For existing NBIS exposure, retain a core position only if sized for financing and execution volatility; consider trimming gains rather than treating contracted power as realized earnings.
• For new capital, stage entry after evidence of capacity conversion and cash funding is available. No compelling short or peer pair is established by the article alone.
• Set an alert for quarterly disclosure of cash capex versus commitments, customer prepayments, debt/equity-linked financing, net cash/debt, and revenue from newly commissioned capacity; reassess if funding shifts materially toward dilution or corporate borrowing.
• Use commissioning milestones and utilization—not headline contract value—as the 1–3 month thesis checks. Persistent schedule slippage or weaker contract economics would invalidate the growth premium; timely deployment with improving cash conversion would support holding or adding.